Risedronate Drug Profile

What is Risedronate?

Risedronate is a prescription medication belonging to a class of drugs called bisphosphonates. It is primarily used to treat and prevent osteoporosis in postmenopausal women and men, helping to reduce the risk of bone fractures. Risedronate works by slowing down bone breakdown and maintaining bone density.

Uses

Risedronate is FDA-approved for several bone-related conditions:

• Postmenopausal osteoporosis treatment and prevention: Reduces fracture risk and increases bone mineral density in women after menopause
• Male osteoporosis: Treats osteoporosis in men to prevent vertebral and non-vertebral fractures
• Glucocorticoid-induced osteoporosis: Prevents and treats bone loss in patients taking corticosteroid medications long-term
• Paget’s disease: Treats this bone disorder characterized by abnormal bone formation and breakdown

How it works

Risedronate inhibits osteoclasts, the cells responsible for breaking down bone tissue. By binding to bone mineral and interfering with osteoclast function, it reduces bone resorption while allowing bone formation to continue. This mechanism helps maintain or increase bone density and reduces the risk of fractures.

Side effects

Common side effects include:

Submit Your Paper

• Stomach pain or upset
• Nausea
• Diarrhea or constipation
• Headache
• Muscle or joint pain
• Dizziness
• Flu-like symptoms
• Back pain

Serious side effects requiring immediate medical attention:

• Severe jaw pain or osteonecrosis of the jaw
• Unusual thigh bone fractures
• Severe bone, joint, or muscle pain
• Difficulty swallowing or chest pain
• Severe heartburn or stomach pain

Warnings and precautions

• Esophageal problems: Patients with esophageal disorders, difficulty swallowing, or inability to sit upright for 30 minutes should avoid risedronate
• Kidney function: Not recommended for patients with severe kidney impairment (creatinine clearance less than 30 mL/min)
• Pregnancy and breastfeeding: Should be avoided during pregnancy and breastfeeding due to potential risks to the developing baby
• Dental procedures: Inform dentist before dental work, as bisphosphonates may increase risk of jaw problems
• Calcium and vitamin D: Adequate intake is essential, as low levels may reduce effectiveness and increase side effect risk

Interactions

Risedronate has several important drug and supplement interactions:

• Calcium supplements: Significantly reduce absorption when taken together; separate by at least 30 minutes
• Antacids: Aluminum, magnesium, or calcium-containing antacids decrease risedronate absorption
• Iron supplements: Can reduce risedronate absorption; take at different times of day
• Aspirin or NSAIDs: May increase risk of stomach irritation when used together
• Multivitamins: Minerals in multivitamins can interfere with absorption
• Proton pump inhibitors: May reduce risedronate effectiveness by altering stomach acid levels
• Food and beverages: All food, drinks (except plain water), and supplements reduce absorption significantly
• Aminoglycosides: May increase risk of low calcium levels when used concurrently

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary by condition and formulation:

• Osteoporosis treatment: 5 mg daily or 35 mg once weekly
• Osteoporosis prevention: 5 mg daily or 35 mg once weekly
• Paget’s disease: 30 mg daily for 2 months

Risedronate must be taken on an empty stomach with plain water first thing in the morning, at least 30 minutes before eating, drinking, or taking other medications. Patients must remain upright for at least 30 minutes after taking the medication. Dosage should always be determined and monitored by a healthcare provider based on individual patient factors, kidney function, and treatment response.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).